TAKEDA PHARMACEUTICAL CO LTD (TAK)
Takeda Pharmaceutical Company Limited is a prominent global biopharmaceutical entity dedicated to the discovery, development, manufacturing, commercialization, and out-licensing of pharmaceutical products. The company's operations extend across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America, Russia, and numerous other Asian and worldwide markets. Its extensive portfolio of medicines targets critical therapeutic areas, including digestive disorders (gastroenterology), rare diseases, plasma-derived treatments, cancer care (oncology), and neurological conditions. Takeda markets these products under various well-recognized brand names, such as Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig. To further its innovative endeavors, Takeda engages in a wide array of strategic partnerships. These include out-licensing arrangements, notably with Neurocrine Biosciences, Inc.; numerous collaboration and in-licensing agreements with institutions like the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., Ovid Therapeutics Inc., and Evox Therapeutics Ltd.; and a licensing deal with ProThera Biologics Inc. The company also fosters research collaborations and licensing agreements with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio. Furthermore, it maintains strategic alliances with Egle Therapeutics SAS, Evotec SE, Neurocrine Biosciences, Inc., Carmine Therapeutics, KSQ Therapeutics, and Anima Biotech. Founded in 1781, Takeda Pharmaceutical Company Limited is headquartered in Tokyo, Japan.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical Company Limited
NYSE:TAKHealthcare · Drug Manufacturers - Specialty & Generic
+1.49%$21.06
CLOSED · Nov 4Prev close$20.75+1.49%Close$21.06+4.10%AH close$21.92
AH$21.92+4.10%vs close
Mkt Cap$67.28B
Float3.16B
O/S3.19B
VOL2.98M sh
$ Vol$62.27M
RVOL0.99×
Inst Own3.3%
SI0.1%
Div Yield3.35%
Dilution
Financials Summary
Revenue$30.19B
Net Income$1.28B
Total Assets$98.07B
Free Cash Flow$3.96B
Debt & Equity
Debt 39%
Equity 61%
Total Debt$30.98B
Total Equity$49.34B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in TAK's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$98.07B
Liabilities$48.73B
Accounts Receivable$5.56B
Accounts Payable$3.12B
Inventory$8.86B
PP&E (Net)$13.46B
Goodwill$36.87B
Intangible Assets$21.7B
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 | FY 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 | 2006-03-31 | 2005-03-31 | 2004-03-31 | 2003-03-31 | 2002-03-31 | 2001-03-31 | 2000-03-31 |
| Revenue | $30.19B | $28.95B | $26.94B | $25.45B | $22.55B | $20.21B | $20.8B | $13.25B | $11.19B | $10.95B | $11.42B | $11.23B | $10.69B | $9.84B | $9.54B | $8.97B | $9.26B | $9.72B | $8.69B | $8.25B | $7.66B | $7.1B | $6.87B | $6.61B | $6.35B | $6.09B | $5.83B |
| YoY Growth | 4.3% | 7.5% | 5.9% | 12.8% | 11.6% | -2.8% | 56.9% | 18.5% | 2.2% | -4.2% | 1.7% | 5.1% | 8.6% | 3.2% | 6.3% | -3.2% | -4.7% | 11.9% | 5.3% | 7.7% | 7.9% | 3.4% | 3.9% | 4.1% | 4.3% | 4.4% | - |
| Cost of Revenue | $14.77B | $9.99B | $9.05B | $7.86B | $6.99B | $6.28B | $6.89B | $4.17B | $3.13B | $3.53B | $3.38B | $3.29B | $3.1B | $2.83B | $2.74B | $2.01B | $1.8B | $1.83B | $1.76B | $1.77B | $1.78B | $1.76B | $1.7B | $1.9B | $2.13B | $2.43B | $2.73B |
| Gross Profit | $15.41B | $18.97B | $17.9B | $17.59B | $15.56B | $13.92B | $13.91B | $9.08B | $8.05B | $7.41B | $8.04B | $7.94B | $7.59B | $7.01B | $6.8B | $6.96B | $7.46B | $7.89B | $6.93B | $6.48B | $5.88B | $5.33B | $5.16B | $4.71B | $4.22B | $3.66B | $3.1B |
| Gross Margin | 51.1% | 65.5% | 66.4% | 69.1% | 69.0% | 68.9% | 66.9% | 68.5% | 72.0% | 67.7% | 70.4% | 70.7% | 71.0% | 71.3% | 71.3% | 77.6% | 80.6% | 81.2% | 79.7% | 78.6% | 76.7% | 75.1% | 75.2% | 71.3% | 66.4% | 60.1% | 53.2% |
| Research and Development | $4.53B | $4.61B | $4.61B | $4B | $3.32B | $2.88B | $3.11B | $2.33B | $2.06B | $1.97B | $2.19B | $2.41B | $2.16B | $2.05B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $7.26B | $6.98B | $6.66B | $6.3B | $5.6B | $5.53B | $6.1B | $4.53B | $3.97B | $3.91B | $4.11B | $3.87B | $3.51B | $6.24B | $5.12B | $4.64B | $4.81B | $5.95B | $0 | $0 | $0 | $0 | $0 | $0 | $2.44B | $0 | $2.02B |
| Other | $0 | $5.21B | $5.27B | $4.18B | $3.72B | $2.29B | $4.07B | $5.74B | $4.47B | $4.46B | $5.03B | $6.34B | $4.55B | $36.72M | $0 | $23.87M | $4.64M | $0 | $4.25B | $3.58B | $3.33B | $2.9B | $2.81B | $2.75B | $0 | $2.23B | $0 |
| Total Operating Expenses | $11.79B | $16.8B | $16.54B | $14.49B | $12.65B | $10.71B | $13.28B | $8.07B | $6.53B | $6.43B | $7.21B | $8.76B | $6.71B | $6.24B | $5.12B | $4.64B | $4.81B | $5.95B | $4.25B | $3.58B | $3.33B | $2.9B | $2.81B | $2.75B | $2.44B | $2.23B | $2.02B |
| Operating Income (EBIT) | $3.62B | $2.16B | $1.35B | $3.1B | $2.91B | $3.22B | $634.49M | $1.3B | $1.53B | $984.94M | $826.72M | -$816.77M | $880.09M | $774.12M | $1.67B | $2.32B | $2.66B | $1.94B | $2.67B | $2.9B | $2.55B | $2.43B | $2.35B | $1.96B | $1.78B | $1.43B | $1.08B |
| Operating Margin | 12.0% | 7.5% | 5.0% | 12.2% | 12.9% | 15.9% | 3.1% | 9.8% | 13.7% | 9.0% | 7.2% | -7.3% | 8.2% | 7.9% | 17.6% | 25.9% | 28.7% | 19.9% | 30.8% | 35.1% | 33.2% | 34.3% | 34.2% | 29.7% | 28.0% | 23.5% | 18.6% |
| Interest Expense | $2.4B | $867.69M | $6.71M | $739.17M | $773.66M | $826.58M | $9.22M | $304.32M | $201.76M | $146.92M | $201.78M | $207.76M | $194.12M | $21M | $11.9M | $8.44M | $9.03M | $10.24M | $2.1M | $1.56M | $2.31M | $2.11M | $2.27M | $2.65M | $4.8M | $6.45M | $7.55M |
| Interest Income | $1.41B | $124.09M | $494K | $34.81M | $29.01M | $11.25M | $651K | $41.83M | $249.88M | $77.56M | $136.78M | $97.04M | $311.51M | $103.02M | $39.79M | $10.94M | $12.49M | $71.91M | $392.18M | $355.41M | $216.18M | $114.36M | $68.85M | $64.01M | $60.73M | $62.73M | $0 |
| Other Income (Expense) | -$1.88B | -$1.06B | -$1.02B | -$729.32M | -$1B | -$903.85M | -$1.02B | -$695.57M | -$155.35M | -$79.12M | -$65.02M | -$102.26M | $123.71M | $66.75M | -$79.3M | $28.36M | -$27.69M | $581.85M | $971.37M | $1.05B | $727.63M | $352.76M | $470.84M | $765.95M | $582.52M | $233.64M | $197.92M |
| Income Before Tax (EBT) | $1.74B | $1.11B | $333.59M | $2.37B | $1.91B | $2.31B | -$383.91M | $599.66M | $1.37B | $905.82M | $761.7M | -$919.03M | $1B | $819.63M | $1.6B | $2.35B | $2.63B | $2.52B | $3.65B | $3.95B | $3.27B | $2.79B | $2.82B | $2.73B | $2.36B | $1.66B | $1.28B |
| Income Tax Expense | $456.71M | $423.01M | -$577.61M | $366.84M | $457.54M | -$62.79M | -$663.79M | -$89.21M | $192.71M | $175.88M | $234.18M | -$15.18M | $311.48M | -$24.52M | $791.21M | $766.67M | $730.92M | $1.02B | $1.38B | $1.81B | $1.27B | $1.01B | $997.86M | $995.17M | $852.4M | $721.32M | $514.67M |
| Net Income | $1.28B | $682.01M | $910.38M | $2B | $1.45B | $2.38B | $279.56M | $689.58M | $1.18B | $726.32M | $506.58M | -$921.17M | $673.99M | $829.35M | $784.6M | $1.57B | $1.88B | $1.48B | $2.25B | $2.12B | $1.98B | $1.75B | $1.8B | $1.72B | $1.49B | $928M | $755.93M |
| Net Income Margin | 4.3% | 2.4% | 3.4% | 7.9% | 6.4% | 11.8% | 1.3% | 5.2% | 10.6% | 6.6% | 4.4% | -8.2% | 6.3% | 8.4% | 8.2% | 17.5% | 20.3% | 15.2% | 25.9% | 25.7% | 25.8% | 24.7% | 26.3% | 26.0% | 23.4% | 15.2% | 13.0% |
| Supplementary Data | |||||||||||||||||||||||||||
| EPS | 63.91 | 34.17 | 46.05 | 102.15 | 73.57 | 120.36 | 14.21 | 34.78 | 119.68 | 73.58 | 51.13 | -46.47 | 67.55 | 94.11 | 78.65 | 157.01 | 188.60 | 144.91 | 209.49 | 193.00 | 176.74 | 156.51 | 160.93 | 153.82 | 133.51 | 83.20 | 67.78 |
| Diluted EPS | 63.91 | 33.62 | 45.58 | 100.97 | 72.94 | 119.48 | 14.13 | 34.78 | 118.78 | 73.13 | 50.86 | -46.47 | 67.47 | 94.09 | 78.63 | 156.98 | 188.57 | 144.90 | 209.49 | 193.00 | 176.74 | 156.51 | 160.93 | 153.82 | 133.51 | 83.20 | 67.78 |
| Weighted Average OS | 3.15B | 3.21B | 3.13B | 3.10B | 3.13B | 3.12B | 3.11B | 1.92B | 1.56B | 1.56B | 1.57B | 1.57B | 1.58B | 1.58B | 1.58B | 1.58B | 1.58B | 1.62B | 1.70B | 1.74B | 1.77B | 1.77B | 3.14B | 3.14B | 3.14B | 3.14B | 3.14B |
| EBITDA | $8.7B | $7.65B | $7.76B | $8.11B | $7.48B | $6.22B | $4.25B | $2.93B | $2.27B | $1.88B | $2.21B | $362M | $2.33B | $2.53B | $2.56B | $3.03B | $3.36B | $3.27B | $3.85B | $4.14B | $3.46B | $2.99B | $3B | $2.92B | $2.54B | $1.88B | $1.5B |
| EBITDA Margin | 28.8% | 26.4% | 28.8% | 31.9% | 33.2% | 30.8% | 20.4% | 22.1% | 20.3% | 17.1% | 19.4% | 3.2% | 21.8% | 25.7% | 26.8% | 33.8% | 36.3% | 33.7% | 44.3% | 50.1% | 45.1% | 42.1% | 43.7% | 44.2% | 40.1% | 30.9% | 25.7% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 | 2006-03-31 | 2005-03-31 | 2004-03-31 | 2003-03-31 | 2002-03-31 | 2001-03-31 |
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash and Cash Equivalents | $3.78B | $2.43B | $2.89B | $3.37B | $5.37B | $6.11B | $4.03B | $4.44B | $1.86B | $2.02B | $2.85B | $4.12B | $4.21B | $1.83B | $2.87B | $1.38B | $1.68B | $1.45B | $10.19B | $10.41B | $10.28B | $7.99B | $6.8B | $6.46B | $4.76B | $4.01B |
| Short-Term Investments | $0 | $129.39M | $95.35M | $127.48M | $159.91M | $231.27M | $99.98M | $147.08M | $509.61M | $358.19M | $686.26M | $387.2M | $1.17B | $102.62M | $39.65M | $9.53M | $3.9B | $3.34B | $9.13B | $962.04M | $1.54B | $1.63B | $1.53B | $748.36M | $1.19B | $562.77M |
| Cash and Short-Term Investments | $3.78B | $2.56B | $2.99B | $3.5B | $5.53B | $6.34B | $4.13B | $4.58B | $2.37B | $2.38B | $3.54B | $4.51B | $5.38B | $3.55B | $2.91B | $5.52B | $5.58B | $4.79B | $10.65B | $11.37B | $11.81B | $9.62B | $8.33B | $7.21B | $5.6B | $4.57B |
| Accounts Receivable | $5.56B | $4.58B | $4.41B | $4.31B | $4.58B | $5.14B | $4.96B | $4.73B | $2.71B | $2.81B | $2.72B | $2.95B | $2.8B | $2.45B | $2.29B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $8.86B | $7.69B | $7.65B | $6.23B | $5.39B | $4.76B | $4.8B | $6.24B | $1.35B | $1.43B | $1.61B | $1.66B | $1.61B | $1.45B | $1.23B | $866.52M | $870.12M | $831.96M | $733.85M | $665.45M | $620.9M | $597.57M | $587.24M | $565.47M | $607.23M | $634.59M |
| Other Current Assets | $1.41B | $1.09B | $1.13B | $1.11B | $891.61M | $906.66M | $1.72B | $3.78B | $391.18M | $1.35B | $816.3M | $489.52M | $281.29M | $336.87M | $273.52M | $3.63B | $3.49B | $3.7B | $2.8B | $2.86B | $2.55B | $2.23B | $2.02B | $1.97B | $2.29B | $1.99B |
| Total Current Assets | $19.61B | $15.93B | $16.17B | $15.15B | $16.39B | $17.14B | $15.6B | $19.28B | $6.82B | $7.97B | $8.68B | $9.61B | $10.06B | $9.19B | $8.08B | $10.02B | $9.94B | $9.32B | $14.18B | $14.9B | $14.99B | $12.45B | $10.93B | $9.75B | $8.5B | $7.2B |
| Long-Term Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment Net | $13.46B | $12.44B | $12.57B | $10.69B | $10B | $9.19B | $8.76B | $8.32B | $3.39B | $3.35B | $3.49B | $3.32B | $3.43B | $3.23B | $3.09B | $2.57B | $2.02B | $1.63B | $1.49B | $1.51B | $1.36B | $1.39B | $1.46B | $1.28B | $1.35B | $1.39B |
| Goodwill | $36.87B | $33.65B | $34.19B | $30.27B | $27.85B | $25.49B | $25.36B | $26.3B | $6.5B | $6.46B | $4.92B | $5.19B | $5.15B | $4.27B | $3.68B | $1.37B | $1.62B | $1.8B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $21.7B | $22.95B | $27.01B | $26.98B | $24.13B | $24.7B | $26.36B | $30.71B | $6.41B | $6.74B | $4.7B | $5.94B | $7.18B | $6.41B | $5.64B | $1.9B | $2.43B | $2.93B | $0 | $0 | $0 | $1.42B | $1.84B | $1.67B | $1.84B | $1.9B |
| Long-Term Investments | $2.85B | $2.29B | $2.72B | $2.39B | $2.09B | $2.2B | $2.33B | $1.94B | $1.92B | $1.91B | $1.01B | $1.59B | $1.28B | -$514.31M | $1.17B | -$3.1B | -$2.65B | -$2.15B | $1.4B | $1.53B | $914.24M | $290.98M | $726.19M | $1.11B | $1.38B | $1.89B |
| Deferred Tax Assets | $3.1B | $2.34B | $2.49B | $2.31B | $2.29B | $2.24B | $1.95B | $562.35M | $410.62M | $751.77M | $1.08B | $976.34M | $1.32B | $1.13B | $1.03B | $167.84M | $41.7M | $70.31M | $27.8M | $117.42M | $79.68M | $79.25M | $33.3M | $35.86M | $33.38M | $32.16M |
| Other Long-Term Assets | $488.74M | $444.12M | $323.63M | $400.16M | $522.03M | $634.07M | $656.22M | $552.75M | $492.75M | $343.81M | $288.16M | $520.76M | $460.38M | $405.8M | $324.23M | $1.62B | $1.8B | $1.69B | $2.24B | $2.89B | $2.79B | $2.17B | $2.34B | $1.95B | $2.54B | $2.42B |
| Total Long-Term Assets | $78.46B | $74.11B | $79.31B | $73.05B | $66.88B | $64.45B | $65.41B | $68.24B | $19.13B | $19.5B | $15.48B | $17.54B | $18.81B | $17.83B | $16.08B | $7.58B | $7.9B | $8.12B | $3.83B | $4.52B | $4.24B | $3.64B | $3.83B | $3.27B | $3.92B | $3.85B |
| Other Assets | $0 | $0 | -$13K | $0 | -$6K | $0 | $0 | $0 | $0 | $0 | $0 | $13K | $6K | $6K | $6K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $98.07B | $90.04B | $95.47B | $88.2B | $83.27B | $81.59B | $81.02B | $87.66B | $25.95B | $27.52B | $24.16B | $27.15B | $28.87B | $25B | $22.6B | $17.61B | $17.84B | $17.44B | $18B | $19.42B | $19.22B | $16.08B | $14.76B | $13.01B | $12.42B | $11.04B |
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payable | $3.12B | $1.95B | $2.02B | $1.94B | $1.87B | $1.47B | $1.34B | $1.34B | $844.9M | $1.52B | $1.21B | $1.08B | $1.17B | $1.07B | $1.11B | $507.55M | $1.24B | $1.51B | $457.92M | $348.73M | $320.5M | $289.01M | $332.65M | $343.8M | $359.86M | $575.54M |
| Short-Term Debt | $3.25B | $3.47B | $2.32B | $2.15B | $1.29B | $139.99M | $3.71B | $6.22B | $114K | $3.44B | $1.44B | $631.69M | $982.02M | $28.47M | $1.55B | $26.09M | $20.76M | $20.31M | $21.24M | $60.46M | $57.58M | $81.78M | $63.05M | $48.59M | $64.08M | $59.7M |
| Current Income Tax Payable | $0 | $0 | $694.51M | $1.47B | $1.27B | $917.56M | $1.15B | $755.04M | $427.77M | $446.03M | $272.56M | $259.53M | $330.69M | $716.78M | $152.27M | $265.26M | $308.85M | $447.2M | $570.4M | $636.55M | $960.17M | $510.52M | $593.06M | $532.69M | $523.03M | $488.9M |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $8.43B | $8.52B | $8.14B | $7.97B | $7.74B | $7.97B | $6.87B | $6.89B | $2.71B | $3.22B | $2.49B | $4.46B | $2.59B | $2.1B | $1.94B | $1.95B | $1.14B | $1.01B | $1.66B | $1.64B | $1.6B | $1.3B | $1.25B | $1.13B | $1.24B | $1.02B |
| Total Current Liabilities | $15.42B | $15.84B | $14.62B | $15.68B | $13.56B | $11.2B | $13.75B | $15.87B | $4.66B | $8.63B | $5.42B | $6.43B | $5.07B | $3.88B | $4.75B | $2.76B | $2.71B | $2.98B | $2.71B | $2.8B | $3.09B | $2.31B | $2.34B | $2.18B | $2.35B | $2.18B |
| Long-Term Liabilities | ||||||||||||||||||||||||||
| Long-Term Debt | $27.73B | $25.06B | $28.29B | $25.55B | $26.17B | $29.15B | $28.48B | $30.12B | $6.23B | $3.79B | $3.41B | $3.98B | $4.45B | $3.68B | $1.9B | $103.55M | $0 | $0 | $7.9M | $12.95M | $21.95M | $35.14M | $29.45M | $30.75M | $34.7M | $42.03M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $170.11M | $222.14M | $718.97M | $1.71B | $2.85B | $3.43B | $4.49B | $4.56B | $573.3M | $969.33M | $780.22M | $986.62M | $1.77B | $1.72B | $1.66B | $709.61M | $895.62M | $895.39M | $378.81M | $787.93M | $0 | $477.05M | $487.05M | $227.53M | $376.7M | $396.38M |
| Other Long-Term Liabilities | $5.41B | $5.08B | $5.89B | $5.1B | $4.78B | $5.09B | $4.43B | $3.58B | $1.74B | $1.76B | $1.85B | $1.82B | $1.52B | $1.33B | $731.82M | $438.11M | $460.04M | $480.23M | $232.79M | $266.91M | $1.28B | $615.91M | $646.78M | $670.2M | $684.01M | $522.51M |
| Total Long-Term Liabilities | $33.31B | $30.37B | $34.89B | $32.36B | $33.8B | $37.67B | $37.39B | $39.16B | $8.54B | $6.58B | $6.04B | $6.78B | $7.75B | $7.07B | $4.76B | $1.35B | $1.45B | $1.48B | $619.5M | $1.07B | $1.3B | $1.13B | $1.16B | $928.48M | $847.39M | $960.92M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $48.73B | $46.21B | $49.51B | $48.04B | $47.36B | $48.88B | $51.14B | $55.03B | $13.2B | $15.21B | $11.46B | $13.21B | $12.82B | $10.95B | $9.51B | $4.11B | $4.16B | $4.46B | $3.33B | $3.86B | $4.38B | $3.44B | $3.5B | $3.11B | $3.2B | $3.14B |
| Stockholders' Equity | ||||||||||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $10.76B | $10.71B | $10.59B | $10.59B | $10.59B | $10.54B | $10.54B | $10.39B | $1.07B | $885.78M | $844.2M | $781.16M | $653.57M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M | $401.52M |
| Retained Earnings | $6.71B | $7.5B | $8.79B | $9.74B | $9.35B | $9.54B | $8.66B | $9.92B | $9.84B | $9.55B | $9.62B | $10.12B | $12.01B | $14.17B | $14.24B | $14.36B | $13.69B | $12.72B | $15.95B | $14.52B | $13.03B | $11.6B | $10.22B | $8.8B | $7.43B | $6.25B |
| Comprehensive Income & Other | $20.91B | $14.86B | $15.86B | $9.53B | $5.9B | $2.31B | $584.92M | $2.21B | -$30.3M | $1.84B | $2.07B | $2.72B | $2.95B | -$1.17B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $31.87B | $25.61B | $26.57B | $19.82B | $15.97B | $12.61B | $10.65B | $12.3B | $1.72B | $1.53B | $1.84B | $2.6B | $2.94B | -$927.11M | -$1.93B | -$1.54B | -$685.66M | -$406.58M | -$1.94B | $374.51M | $1.41B | $650.5M | $636.92M | $704.92M | $1.14B | $1.01B |
| Total Equity | $49.34B | $43.82B | $45.96B | $40.15B | $35.91B | $32.69B | $29.85B | $32.6B | $12.62B | $11.97B | $12.31B | $13.5B | $15.61B | $13.65B | $12.72B | $13.22B | $13.41B | $12.71B | $14.41B | $15.29B | $14.84B | $12.65B | $11.25B | $9.91B | $8.97B | $7.66B |
| Minority Interest | $7.67M | $5.66M | $4.68M | $3.47M | $3.18M | $26.16M | $25.3M | $25.31M | $126.29M | $345.68M | $395.01M | $436.83M | $441.68M | $400.75M | $376.12M | $282.67M | $274.29M | $267.86M | $263.82M | $258.27M | $0 | $0 | $0 | $0 | $248.03M | $235.18M |
| Total Liabilities and Equity | $98.07B | $90.03B | $95.47B | $88.2B | $83.27B | $81.57B | $80.99B | $87.64B | $25.82B | $27.18B | $23.77B | $26.71B | $28.43B | $24.6B | $22.23B | $17.32B | $17.57B | $17.17B | $17.74B | $19.16B | $19.22B | $16.08B | $14.76B | $13.01B | $12.17B | $10.81B |
| Supplementary Data | ||||||||||||||||||||||||||
| Total Debt | $30.98B | $28.53B | $30.61B | $27.69B | $27.46B | $29.29B | $32.19B | $36.34B | $6.23B | $7.23B | $4.85B | $4.61B | $5.43B | $3.79B | $3.43B | $225.29M | $118.82M | $124.89M | $29.14M | $73.41M | $79.53M | $116.92M | $92.5M | $79.34M | $98.79M | $101.73M |
| Net Debt | $27.21B | $26.1B | $27.72B | $24.32B | $22.09B | $23.19B | $28.16B | $31.9B | $4.37B | $5.22B | $2B | $488.04M | $1.23B | $346.59M | $556.79M | -$5.29B | -$1.57B | -$1.33B | -$1.48B | -$10.34B | -$10.2B | -$7.87B | -$6.71B | -$6.38B | -$4.31B | -$3.91B |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 | FY 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 | 2006-03-31 | 2005-03-31 | 2004-03-31 | 2003-03-31 | 2002-03-31 | 2001-03-31 | 2000-03-31 |
| Operating Activities | |||||||||||||||||||||||||||
| Net Income | -$961.3M | $683.37M | $911.2M | $2B | $1.45B | $2.38B | $279.87M | $853.59M | $1.18B | $729.94M | $527.52M | -$903.85M | $692.31M | $952.26M | $1.6B | $2.35B | $2.63B | $2.52B | $3.65B | $3.95B | $3.27B | $2.79B | $2.82B | $2.73B | $2.36B | $1.66B | $0 |
| Depreciation & Amortization | $4.56B | $4.81B | $4.6B | $4.2B | $3.69B | $3.54B | $3.69B | $1.57B | $1.15B | $1.08B | $1.25B | $1.65B | $1.36B | $1.56B | $949.09M | $674.39M | $725.59M | $746.17M | $200.25M | $182.12M | $181.54M | $197.32M | $177.46M | $189.33M | $179.65M | $212.35M | $210.83M |
| Deferred Income Tax | $61.74M | $423.01M | -$577.61M | $366.84M | $457.54M | -$62.79M | -$663.79M | -$47.19M | $192.71M | $175.88M | $234.18M | -$15.18M | $311.48M | -$206.7M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $459.87M | $460.46M | $447.84M | $383.39M | $274.09M | $238M | $184.03M | $126.91M | $117.6M | $97.22M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||||||||||||||||||||||
| Accounts Receivable | -$443.39M | -$372.57M | $95.44M | $474.74M | $804.39M | -$58.87M | -$220.07M | -$84.56M | -$4.09M | -$235.8M | $78.18M | -$205.47M | -$268.59M | $5.26M | $87.09M | -$128.03M | $105.5M | -$192.02M | $43.17M | -$189.7M | -$83.13M | -$147.86M | -$54.68M | $111.64M | $37.02M | -$267.77M | -$43.78M |
| Inventory | -$387.32M | -$221M | -$731.39M | -$500.19M | -$291.61M | $164.16M | $868.83M | $320.49M | $86.69M | $24.56M | -$43.25M | -$91.93M | -$106.91M | -$85.08M | $311.61M | -$3.52M | -$46.57M | -$69.49M | -$91.69M | -$44.56M | -$35.68M | -$21.47M | -$25.11M | -$32.67M | -$10.18M | -$11.03M | $9.57M |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $43.36M | $0 | $0 | $0 | $0 | $0 | $10.31M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $2.09B | $218.39M | -$981.76M | -$134.19M | $110.33M | $1.64B | -$5.28M | $168.35M | -$41.26M | $398.76M | -$1.72B | $1.96B | $39.77M | -$1.84M | $0 | $73.67M | $30.48M | $28.23M | -$6.53M | $7.67M | $55.54M | -$11.47M | -$22.97M | -$36.5M | -$3.73M | $57.36M | $0 |
| Total Working Capital Change | $1.26B | -$375.18M | -$1.62B | -$159.65M | $623.1M | $1.74B | $643.48M | $404.28M | $84.7M | $187.52M | -$1.69B | $1.66B | -$335.73M | -$81.66M | $409.01M | -$57.88M | $89.4M | -$233.28M | -$55.05M | -$226.6M | -$63.28M | -$180.8M | -$102.76M | $42.47M | $23.12M | -$221.43M | -$34.21M |
| Other Non-Cash Items | $1.2B | $677.45M | $762.61M | -$617.64M | $602.87M | -$1.44B | $100.51M | -$827.08M | -$338.02M | -$622.24M | -$159.34M | -$1.23B | -$1.09B | -$124.42M | -$826.71M | -$898.55M | -$1.03B | -$969.59M | -$1.94B | -$2.58B | -$1.03B | -$936.35M | -$927.92M | -$1.3B | -$1.04B | -$309.49M | $827.87M |
| Net Cash from Operating | $6.58B | $6.68B | $4.53B | $6.17B | $7.1B | $6.39B | $4.23B | $2.08B | $2.39B | $1.65B | $161.08M | $1.15B | $939.78M | $2.1B | $2.13B | $2.07B | $2.41B | $2.06B | $1.85B | $1.32B | $2.36B | $1.87B | $1.97B | $1.66B | $1.52B | $1.34B | $1B |
| Investing Activities | |||||||||||||||||||||||||||
| Capital Expenditures | -$1.11B | -$1.27B | -$1.11B | -$888.83M | -$778.84M | -$702.72M | -$803.05M | -$490.85M | -$423.41M | -$389.64M | -$308.11M | -$304.78M | -$316.64M | -$527.34M | -$391.18M | -$784.61M | -$549.51M | -$249.38M | -$206.12M | -$184.21M | -$202.8M | -$339.14M | -$342.24M | -$211.55M | -$237.11M | -$170.24M | -$223.84M |
| Acquisitions | $212.21M | $488.11M | $126.12M | $50.29M | -$135.71M | $3.35B | $2.89B | -$18.16B | $358.62M | -$3.32B | -$44.56M | $0 | -$21.12M | -$510.69M | -$6.57B | $0 | $0 | $0 | -$11.1M | $95.27M | $68.07M | -$183.84M | $0 | $343.46M | $372.27M | $104.49M | $0 |
| Purchases of Investments | -$110.15M | -$703.84M | -$253.18M | -$64.15M | -$52.71M | -$79.6M | -$47.72M | -$108.05M | -$106.69M | -$518.84M | -$252.87M | -$22.57M | -$895.33M | -$25.3M | -$3.61M | -$25.62M | -$151.2M | -$5.64B | -$1.61B | -$2.09B | -$2.97B | -$2.47B | -$1.73B | -$1.14B | -$2.19B | -$1.31B | -$6.43M |
| Sales of Investments | $44.43M | $186.05M | $50.69M | $140.63M | $106.93M | $471.43M | $312.18M | $410.96M | $257.46M | $475.63M | $356.74M | $1.04B | $330.29M | $406.5M | $3.09M | $132.52M | $83.46M | $898.05M | $2.31B | $3.27B | $3.14B | $2.5B | $1.05B | $1.68B | $1.47B | $1.26B | $1.04B |
| Other Investing Activities | -$1.37B | -$1.02B | -$1.75B | -$3.07B | -$391.64M | -$553.93M | -$501.14M | $427.16M | -$675.82M | -$394.65M | -$201.17M | -$140.33M | -$70.71M | -$171.46M | $50.81M | $50.5M | -$125.38M | $143.85M | $157.91M | -$350.63M | $3.12M | $37.17M | $145.04M | $217.55M | $1.38B | -$250.14M | -$1.13B |
| Net Cash from Investing | -$2.33B | -$2.32B | -$2.93B | -$3.84B | -$1.25B | $2.49B | $1.85B | -$17.92B | -$589.84M | -$4.14B | -$449.97M | $577.23M | -$973.51M | -$828.29M | -$6.91B | -$627.2M | -$742.63M | -$4.85B | $642.96M | $735.5M | $41.49M | -$456.9M | -$880.39M | $885.61M | $791.4M | -$368.08M | -$326.54M |
| Financing Activities | |||||||||||||||||||||||||||
| Debt Repaid | -$2.17B | $2.16B | $1.74B | $2.05B | $3.79B | $3.23B | $1.48B | -$17.66B | -$1.58B | -$407.27M | -$315.88M | $755.09M | -$1.58B | -$1.5B | -$1.89B | - | - | $5.06M | $8.85M | $13.12M | $8.64M | -$18.88M | $227K | $5.15M | $4.83M | $29.21M | -$7M |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | -$326.09M | -$327.71M | -$14.7M | -$170.17M | -$489.93M | -$13.53M | -$23.61M | -$7.41M | -$118.52M | -$146.08M | -$141.21M | -$111.13M | -$234K | -$152K | -$101K | -$316K | -$215K | -$1.77B | -$813.64M | -$1.35B | -$986K | -$1.05M | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1.97B | -$1.91B | -$1.81B | -$1.77B | -$1.79B | -$1.79B | -$1.79B | -$903.33M | -$896.64M | -$895.34M | -$894.4M | -$895.02M | -$898.16M | -$898.06M | -$897.4M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$849.24M | -$522.93M | -$419.68M | -$743.96M | -$686.21M | -$899.54M | -$839.21M | -$449.56M | -$78.62M | -$105.66M | -$69.12M | -$140.75M | -$64.61M | -$32.84M | -$21.98M | -$23.86M | -$20.99M | -$18.68M | -$12.45M | -$9.88M | -$8.55M | -$9.4M | -$6.31M | -$15.84M | -$13.42M | -$2.29M | -$6.36M |
| Net Cash from Financing | -$3.14B | -$4.75B | -$2.24B | -$4.48B | -$6.76B | -$6.88B | -$6.35B | $18.62B | -$2.06B | $1.83B | -$788.87M | -$1.9B | $609.81M | -$961.78M | $2.49B | -$926.03M | -$935.52M | -$2.69B | -$1.66B | -$2B | -$564.23M | -$467.06M | -$375M | -$372.77M | -$332.75M | -$264.83M | -$176.35M |
| Forex Effect | $217.83M | -$71.94M | $165.59M | $144.89M | $181.73M | $79M | -$137.54M | -$197.59M | -$28.85M | -$36.28M | -$210.17M | $103.18M | $185.17M | $265.61M | -$346.66M | -$384.89M | -$133.99M | $73.71M | -$1.05B | $74.12M | $449.04M | $96.04M | -$374.91M | -$126.16M | $148.34M | $52.83M | -$31.09M |
| Net Change in Cash | $1.33B | -$459.32M | -$478.55M | -$2B | -$736.35M | $2.08B | -$411.43M | $2.57B | -$295.29M | -$833.94M | -$1.29B | -$68.28M | $761.25M | $577.14M | -$2.64B | $127.84M | $596.51M | -$5.4B | -$217.72M | $135.6M | $2.29B | $1.19B | $335.71M | $2.05B | $2.13B | $756.76M | $492.62M |
| Supplementary Data | |||||||||||||||||||||||||||
| Operating Cash Flow | $6.58B | $6.68B | $4.53B | $6.17B | $7.1B | $6.39B | $4.23B | $2.08B | $2.39B | $1.65B | $161.08M | $1.15B | $939.78M | $2.1B | $2.13B | $2.07B | $2.41B | $2.06B | $1.85B | $1.32B | $2.36B | $1.87B | $1.97B | $1.66B | $1.52B | $1.34B | $1B |
| Capital Expenditure | -$2.62B | -$2.4B | -$3.04B | -$4B | -$1.18B | -$1.49B | -$1.38B | -$847.48M | -$810.5M | -$707.91M | -$536.22M | -$687M | -$496.17M | -$709.38M | -$448.92M | -$784.61M | -$549.51M | -$249.38M | -$206.12M | -$184.21M | -$202.8M | -$339.14M | -$342.24M | -$211.55M | -$237.11M | -$170.24M | -$223.84M |
| Free Cash Flow | $3.96B | $4.28B | $1.49B | $2.17B | $5.92B | $4.89B | $2.86B | $1.23B | $1.58B | $943.67M | -$375.14M | $466.35M | $443.61M | $1.39B | $1.68B | $1.28B | $1.86B | $1.81B | $1.64B | $1.14B | $2.16B | $1.53B | $1.62B | $1.45B | $1.28B | $1.17B | $780.66M |
| Cash at Beginning | $2.43B | $2.89B | $3.37B | $5.37B | $6.11B | $4.03B | $4.44B | $1.86B | $2.16B | $2.85B | $4.14B | $4.21B | $3.45B | $2.87B | $5.51B | $5.39B | $4.79B | $10.19B | $10.41B | $10.28B | $7.99B | $6.8B | $6.46B | $4.41B | $2.29B | $1.53B | $1.04B |
| Cash at End | $3.76B | $2.43B | $2.89B | $3.37B | $5.37B | $6.11B | $4.03B | $4.44B | $1.86B | $2.02B | $2.85B | $4.14B | $4.21B | $3.45B | $2.87B | $5.51B | $5.39B | $4.79B | $10.19B | $10.41B | $10.28B | $7.99B | $6.8B | $6.46B | $4.41B | $2.29B | $1.53B |